Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD23 and chronic lymphocytic leukemia

M Sarfati1

  • 1Notre-Dame Hospital Research Center, University of Montréal, Canada.

Blood Cells
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

This study investigates the role of CD23 in chronic lymphocytic leukemia (CLL). Findings suggest CD23 may be involved in the proliferation of leukemic B cells, not just a disease marker.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recruitment of activated neutrophils correlates with disease severity in adult Crohn's disease.

Clinical and experimental immunology·2018
Same author

Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy.

The British journal of dermatology·2016
Same author

Soluble CD23 measurement by CBA: a convenient and reliable quantification method in chronic lymphocytic leukemia.

Cytometry. Part B, Clinical cytometry·2013
Same author

Soluble CD23 measurement by CBA: A convenient and reliable quantification method in Chronic Lymphocytic Leukemia.

Cytometry. Part B, Clinical cytometry·2013
Same author

Basophils are recruited to inflamed lungs and exacerbate memory Th2 responses in mice and humans.

Allergy·2012
Same author

The retinoid, 6-[3-adamantyl-4-hydroxyphenyl]-2-napthalene carboxylic acid, controls proliferative, morphological, and inflammatory responses involved in microglial activation without cytotoxic effects.

Neuroscience·2011
Same journal

In vitro and in vivo studies of stromal niches.

Blood cells·1994
Same journal

Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.

Blood cells·1994
Same journal

Enrichment for primitive hemopoietic progenitors of marrow cells from 5-fluorouracil-treated mice and normal mice.

Blood cells·1994
Same journal

Protein tyrosine phosphorylation in the regulation of hematopoiesis by receptors of the cytokine-receptor superfamily.

Blood cells·1994
Same journal

Lysis of blood platelets by human osteosarcoma cells in vitro.

Blood cells·1994
Same journal

Development of hemopoietic bone marrow within the ectopic bone induced by bone morphogenetic protein.

Blood cells·1994
See all related articles

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Chronic lymphocytic leukemia (CLL) is characterized by abnormal B cell proliferation.
  • CD5 positive B cells are the hallmark of CLL, arrested at an intermediate differentiation stage.
  • CD23 is a B cell surface antigen, the low-affinity IgE receptor (Fc epsilon RII).

Purpose of the Study:

  • To establish the link between CD23 expression and CLL.
  • To investigate the potential role of CD23 in the proliferation of leukemic B cells in CLL.

Main Methods:

  • Analysis of CD23 expression in CLL patient samples.
  • Investigating the functional role of CD23 in B cell proliferation models.

Main Results:

Related Experiment Videos

  • CD23 is consistently expressed on CLL B cells.
  • Evidence suggests CD23 may actively contribute to leukemic cell proliferation.

    • Conclusions:

    • CD23 is more than a marker; it may play a functional role in CLL pathogenesis.
    • Targeting CD23 could be a potential therapeutic strategy for CLL.